Følg Karo Pharma

Tags

Forkjølelse

Weifa ASA to launch  a new medicinal product for  insomnia in Norway

Weifa ASA to launch a new medicinal product for insomnia in Norway

Pressemeldinger   •   aug 10, 2016 14:58 CEST

Weifa ASA is pleased to announce the launch of Zonat® tablets, which is indicated for short-term symptomatic treatment of occasional insomnia in adults over 18 years old. Zonat® contains the antihistamine doxylamine, which is well established as a non-prescription (OTC) product for occasional insomnia in several European countries. In Norway Zonat® will require medical prescription.